Abstract
The data from two prospective randomised phase III trials that were initiated by the West Midlands Ovarian Cancer Study Group (WMOCSG) in 1981 and 1986, recruiting 167 and 195 patients respectively, have been pooled and the survival patterns of the 362 patients treated for advanced epithelial ovarian cancer within clinical trials in the West Midlands over the 10 year period (1981-91) have been explored. All patients had histologically proven epithelial ovarian cancer and all had residual disease after primary surgery, with the majority having stage III/IV disease. The primary treatment for all patients was debulking surgery followed by platinum-based chemotherapy. Eligible patients were further randomised to undergo a second debulking operation. The main end point, survival, was assessed using Kaplan-Meier curves and the log-rank test. A Cox proportional hazards model identified performance status (P = 0.002), residual disease (P = 0.005) and albumin level (P = 0.04) as independent prognostic factors. A multivariate model to predict survival curves for patients with the best and worst prognoses was developed with predicted 5 year survival of 30% and 3% for those in the best and worst prognostic groups respectively. The identification of clinical interventions to improve outcome is an urgent matter since the prognosis for patients with advanced ovarian cancer remains poor.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Dembo A. J., Van Dyk J., Japp B., Bean H. A., Beale F. A., Pringle J. F., Bush R. S. Whole abdominal irradiation by a moving-strip technique for patients with ovarian cancer. Int J Radiat Oncol Biol Phys. 1979 Nov-Dec;5(11-12):1933–1942. doi: 10.1016/0360-3016(79)90942-8. [DOI] [PubMed] [Google Scholar]
- Griffiths C. T., Fuller A. F. Intensive surgical and chemotherapeutic management of advanced ovarian cancer. Surg Clin North Am. 1978 Feb;58(1):131–142. doi: 10.1016/s0039-6109(16)41440-4. [DOI] [PubMed] [Google Scholar]
- Griffiths C. T., Parker L. M., Fuller A. F., Jr Role of cytoreductive surgical treatment in the management of advanced ovarian cancer. Cancer Treat Rep. 1979 Feb;63(2):235–240. [PubMed] [Google Scholar]
- Luesley D., Lawton F., Blackledge G., Hilton C., Kelly K., Rollason T., Wade-Evans T., Jordan J., Fielding J., Latief T. Failure of second-look laparotomy to influence survival in epithelial ovarian cancer. Lancet. 1988 Sep 10;2(8611):599–603. doi: 10.1016/s0140-6736(88)90640-x. [DOI] [PubMed] [Google Scholar]
- Neijt J. P., ten Bokkel Huinink W. W., van der Burg M. E., van Oosterom A. T., Willemse P. H., Vermorken J. B., van Lindert A. C., Heintz A. P., Aartsen E., van Lent M. Long-term survival in ovarian cancer. Mature data from The Netherlands Joint Study Group for Ovarian Cancer. Eur J Cancer. 1991;27(11):1367–1372. doi: 10.1016/0277-5379(91)90011-2. [DOI] [PubMed] [Google Scholar]
- Redman C. W., Warwick J., Luesley D. M., Varma R., Lawton F. G., Blackledge G. R. Intervention debulking surgery in advanced epithelial ovarian cancer. Br J Obstet Gynaecol. 1994 Feb;101(2):142–146. doi: 10.1111/j.1471-0528.1994.tb13080.x. [DOI] [PubMed] [Google Scholar]
- Swenerton K. D., Hislop T. G., Spinelli J., LeRiche J. C., Yang N., Boyes D. A. Ovarian carcinoma: a multivariate analysis of prognostic factors. Obstet Gynecol. 1985 Feb;65(2):264–270. [PubMed] [Google Scholar]
- Venesmaa P. Epithelial ovarian cancer: impact of surgery and chemotherapy on survival during 1977-1990. Obstet Gynecol. 1994 Jul;84(1):8–11. [PubMed] [Google Scholar]
- van Houwelingen J. C., ten Bokkel Huinink W. W., van der Burg M. E., van Oosterom A. T., Neijt J. P. Predictability of the survival of patients with advanced ovarian cancer. J Clin Oncol. 1989 Jun;7(6):769–773. doi: 10.1200/JCO.1989.7.6.769. [DOI] [PubMed] [Google Scholar]